Coastar Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
5
Coastar Therapeutics General Information
Description
Developer of a novel drug delivery platform designed to perform repeated virus dosing. The company's platform uses human cell lipids which contain self-identifying motifs, to protect the cancer-destroying virus from being neutralized by neutralizing antibodies and immune cells, enabling medical practitioners to protect the cancer-killing virus from the patient's immune clearance and deliver the payload to the tumor site for cancer-killing and immunotherapy.
Contact Information
Website
www.coastartherapeutics.comCorporate Office
- 9520 Padgett Street
- Suite101
- San Diego, CA 92126
- United States
Corporate Office
- 9520 Padgett Street
- Suite101
- San Diego, CA 92126
- United States
Coastar Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 10-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 3. Later Stage VC | 10-Nov-2022 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 30-Jun-2021 | $740K | $1.24M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 12-Oct-2020 | $500K | $500K | Completed | Pre-Clinical Trials |
Coastar Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Coastar Therapeutics Patents
Coastar Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023028084-A2 | Methods and compositions of nucleic acid encapsulated within external membranes | Inactive | 27-Aug-2021 | ||
| WO-2023028084-A3 | Methods and compositions of nucleic acid encapsulated within external membranes | Inactive | 27-Aug-2021 | ||
| AU-2020315645-A1 | Process of making membrane lipid coated nanoparticles | Pending | 16-Jul-2019 | ||
| EP-3999116-A1 | Process of making membrane lipid coated nanoparticles | Inactive | 16-Jul-2019 | ||
| EP-3999116-A4 | Process of making membrane lipid coated nanoparticles | Inactive | 16-Jul-2019 | C12N7/00 |
Coastar Therapeutics Signals
Coastar Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CONNECT (San Diego) | Accelerator/Incubator | |||
| Endless Frontier Labs | Accelerator/Incubator | Minority | ||
| Panacea Capital (California) | Venture Capital | Minority | ||
| Proxima Capital | Venture Capital | Minority | ||
| Luminor International Management | Venture Capital | Minority |
Coastar Therapeutics FAQs
-
When was Coastar Therapeutics founded?
Coastar Therapeutics was founded in 2017.
-
Where is Coastar Therapeutics headquartered?
Coastar Therapeutics is headquartered in San Diego, CA.
-
What is the size of Coastar Therapeutics?
Coastar Therapeutics has 8 total employees.
-
What industry is Coastar Therapeutics in?
Coastar Therapeutics’s primary industry is Drug Delivery.
-
Is Coastar Therapeutics a private or public company?
Coastar Therapeutics is a Private company.
-
What is Coastar Therapeutics’s current revenue?
The current revenue for Coastar Therapeutics is .
-
How much funding has Coastar Therapeutics raised over time?
Coastar Therapeutics has raised $5.24M.
-
Who are Coastar Therapeutics’s investors?
CONNECT (San Diego), Endless Frontier Labs, Panacea Capital (California), Proxima Capital, and Luminor International Management have invested in Coastar Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process